Send me real-time posts from this site at my email

Trading Ideas? : Last week's notable insider stock transactions

Trading Ideas can sometimes be seen by looking at what a company insiders are doing.

It is assumed they know something that we don't. So sometimes look thru this list for new ideas.


Molecular Templates moved up approximately 28% after insider Biotech Target purchased almost 4M shares.


NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from December 7 through December 11 include:

  • Officer of Sinclair Broadcast Group ($SBGI) Frederick Smith purchased 300,000 shares of company stock at $28.72 for a total transaction value of $8,616,000
  • Beneficial owner of Molecular Templates ($MTEM) Biotech Target purchased 445,000 shares of company stock at $8.38 per share for a total transaction value of $3,727,409
  • Beneficial owner of Lazydays Holdings ($LAZY) Coliseum Capital purchased 49,300 shares of company stock at $13.99 per share for a total transaction value of $689,707
  • Chairman of Crown Castle International ($CCI) Landis Martin purchased 2,100 shares of company stock at $157.28 per share for a total transaction value of $330,282
  • CFO of ShotSpotter ($SSTI) Alan Stewart purchased 6,091 shares of company stock at $32.80 per share for a total transaction value of $199,787.

NOTABLE INSIDER SALES: Significant insider sales in the prior week from December 7 through December 11 include:

  • VP of Adaptive Biotechnologies ($ADPT) Susan Bobulsk sold 25,000 shares of company stock at $55.00 per share for a total transaction value of $1,375,000
  • VP of Arthur J Gallagher ($AJG) Walter Bay sold 12,600 shares of company stock at $119.23 per share for a total transaction value of $1,502,298
  • CEO of Advanced Micro Devices ($AMD) Lisa Su sold 150,000 shares of company stock at $92.89 per share for a total transaction value of $13,933,185
  • VP of Ambarella ($AMBA) Yun-lung Chen sold 6,027 shares of company stock at $89.16 per share for a total transaction value of $537,373
  • CEO of Arrowhead Pharmaceuticals ($ARWR) Christopher Richard Anzalone sold 55,000 shares of company stock at $68.73 per share for a total transaction value of $3,780,348

NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTION: Shares of Molecular Templates advanced 28% after insider Biotech Target purchased 445,000 shares of company stock.


Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal.

If you liked this article, please click the LIKE (thumbs up) button.

Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so).

Follow us/bookmark us and check back occasionally for additional articles or comments on our page...

Wild Tiger Trading - start/main page.

.
Are you interested in trading stocks to supplement your income or make a living? Maybe become a professional trader? Many traders have the skills and nerves to trade, but not the upfront capital. Well now that problem is solved!
Try2BeFunded
has expanded its trading program! If you're a novice or experienced trader, you can earn access to a trading account with up to $100,000! To learn more about how to qualify, click HERE and give it a shot! You have nothing to lose it is free to try.

Trade Try2BeFunded today!

.

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue